<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0305">
 <label>61</label>
 <element-citation publication-type="journal" id="h0305">
  <person-group person-group-type="author">
   <name>
    <surname>Rizza</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Bhatia</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Zeuli</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Temesgen</surname>
    <given-names>Z.</given-names>
   </name>
  </person-group>
  <article-title>Ibalizumab for the treatment of multidrug-resistant HIV-1 infection</article-title>
  <source>Drugs Today (Barcelona, Spain: 1998)</source>
  <volume>55</volume>
  <issue>1</issue>
  <year>2019</year>
  <fpage>25</fpage>
  <lpage>34</lpage>
 </element-citation>
</ref>
